Direct costs of Health care for Breast Cancer, the case of a Health manteinance Organization in Colombia

Moreno, Julián; Muñoz-Galindo, IM; Guarin, N.E.; Díaz, Jorge Aurelio; Arevalo, HO

doi:10.1016/j.jval.2015.03.1480

Cited by 3 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The costs per year ranged from $10,531 to $30,826 in 2020 international dollars for stages I and IV, respectively [ 30 ]. Similarly, Moreno et al evaluated the costs of delivering health care services to patients with BC affiliated with an HMO from 2010 to 2014 [ 15 ]. The authors estimated a one-year cost per patient ranging from $5,214 to $8,350 depending on the year in the study period.…”

Section: Discussionmentioning

confidence: 99%

Net costs of breast cancer in Colombia: a cost-of-illness study based on administrative claims databases

Torres,

Alarcón,

Reyes-Sanchez

et al. 2024

Cost Eff Resour Alloc

View full text Add to dashboard Cite

Background Breast Cancer (BC) is associated with substantial costs of healthcare; however, real-world data regarding these costs in Colombia is scarce. The contributory regime provides healthcare services to formal workers and their dependents and covers almost half of the population in Colombia. This study aims to describe the net costs of healthcare in women with BC covered by the contributory regime in Colombia in 2019 from the perspective of the Colombian Health System. Methods The main data source was the Capitation Sufficiency Database, an administrative database that contains patient-level data on consumption of services included in the National Formulary (PBS, in Spanish Plan de Beneficios en Salud). Data on consumption of services not included in the PBS (non-PBS) were calculated using aggregated data from MIPRES database. All direct costs incurred by prevalent cases of BC, from January 1 to December 31, 2019, were included in the analysis. The net costs of the disease were estimated by multiplying the marginal cost and the expected number of cases with BC by region and age group. Marginal costs were defined as the costs of services delivered to patients with BC after subtracting the expected costs of health services due to age, comorbidity burden or region of residence. To calculate these costs, we used Propensity Score Matching in the main analysis. All costs were expressed in 2019 international dollars. Productivity losses, transportation expenses, and caregiving costs were not included. Results A total of 46,148 patients with BC were identified. Total net costs were $387 million (95% CI $377 to $396 million), 60% associated with non-PBS services. Marginal costs were $8,366 (95% Confidence Interval $8,170 to $8,573), with substantial variations between regions age groups (from $3,919 for older patients in the Amazonia region to $10,070 for younger patients in the Pacific region). The costs for PBS services were higher for ambulatory services and for patients who died during 2020. Conclusions BC imposes a substantial economic burden for the Colombian Health System with important variations in net costs between regions and age groups. Patients near death and ambulatory services were associated with higher costs of healthcare.

show abstract

Section: Discussionmentioning

confidence: 99%

Net costs of breast cancer in Colombia: a cost-of-illness study based on administrative claims databases

Torres,

Alarcón,

Reyes-Sanchez

et al. 2024

Cost Eff Resour Alloc

View full text Add to dashboard Cite

show abstract

“…This information can help estimate the 4 4 magnitude of diseases in monetary terms, justify preventive or therapeutic strategies, and provide an economic framework for the evaluation of programs, among other useful applications (9). BC has been the subject of several COI studies (10)(11)(12)(13)(14)(15)(16); however, there exists great variability between the estimates from these studies in Colombia. Furthermore, there is no information regarding the net costs associated to BC after adjusting for comorbidities.…”

Section: Introductionmentioning

confidence: 99%

Net Costs of Breast Cancer in Colombia: A Cost-of- Illness Study Based on Administrative Claims Databases

Torres,

Alarcón,

Reyes-Sanchez

et al. 2023

Preprint

View full text Add to dashboard Cite

Background Breast Cancer (BC) is associated with substantial costs of healthcare; however, real-world data regarding these costs in Colombia is scarce. The contributory regime provides healthcare services to formal workers and their dependents and covers almost half of the population in Colombia. This study aims to describe the net costs of healthcare in women with BC covered by the contributory regime in Colombia in 2019 from the perspective of the Colombian Health System. Method The main data source was the Capitation Sufficiency Database, an administrative database that contains patient-level data on consumption of services included in the National Formulary (PBS, in Spanish Plan de Beneficios en Salud). Data on consumption of services not included in the PBS (non-PBS) were calculated using aggregated data from MIPRES database. All direct costs incurred by prevalent cases of BC, from January 1 to December 31, 2019, were included in the analysis. The net costs of the disease were estimated by multiplying the marginal cost and the expected number of cases with BC by region and age group. Marginal costs were defined as the costs of services delivered to patients with BC after subtracting the expected costs of health services due to age, comorbidity burden or region of residence. To calculate these costs, we used Propensity Score Matching in the main analysis. All costs were expressed in 2019 international dollars. Productivity losses, transportation expenses, and caregiving costs were not included. Results A total of 46,148 patients with BC were identified. Total net costs were $392.7 million (95% CI $386.4 to $404.9 million) 60% associated with non-PBS services. Marginal costs were $8,507 (95% Confidence Interval $8,305 to $8,708), with substantial variations between regions age groups (from $4,509 for older patients in the Amazonia region to $12,646 for younger patients in the Pacific region). The costs for PBS services were higher for ambulatory services and for patients who died during 2020. Conclusions BC imposes a substantial economic burden for the Colombian Health System with important variations in net costs between regions and age groups. Patients near death and ambulatory services were associated with higher costs of healthcare.

show abstract

Direct Medical Costs, Productivity Loss Costs and Out-Of-Pocket Expenditures in Women with Breast Cancer in Latin America and the Caribbean: A Systematic Review

et al. 2021

View full text Add to dashboard Cite

Direct costs of Health care for Breast Cancer, the case of a Health manteinance Organization in Colombia

Cited by 3 publications

References 0 publications

Net costs of breast cancer in Colombia: a cost-of-illness study based on administrative claims databases

Net costs of breast cancer in Colombia: a cost-of-illness study based on administrative claims databases

Net Costs of Breast Cancer in Colombia: A Cost-of- Illness Study Based on Administrative Claims Databases

Direct Medical Costs, Productivity Loss Costs and Out-Of-Pocket Expenditures in Women with Breast Cancer in Latin America and the Caribbean: A Systematic Review

Contact Info

Product

Resources

About